Medicure (MCUJF) EPS (Weighted Average and Diluted) (2009 - 2026)
Medicure (MCUJF) recorded quarterly EPS (Weighted Average and Diluted) of -$10150.0 in Q1 2026, up 28.51% quarter-over-quarter from -$14198.5 in Q4 2025, and down 2.38% on a YoY basis from -$10397.2 in Q1 2025.
Medicure (MCUJF) EPS (Weighted Average and Diluted) (2009 - 2026) Analysis & Trends
Medicure's EPS (Weighted Average and Diluted) history runs 16 years deep, the most recent figure standing at -$10150.0 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 2.38% year-over-year to -$10150.0; the TTM figure through Mar 2026 stood at -$10150.0 (down 2.38% YoY), while the FY2025 annual figure was -$0.49, down 581.18% from the prior year.
- EPS (Weighted Average and Diluted) was -$10150.0 for Q1 2026 at Medicure, up from -$14198.5 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $66800.0 in Q3 2024 to a low of -$18111.1 in Q4 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged $5594.5 across 5 years, with a median of $1620.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) jumped 4237.66% in 2024, then plunged 683.19% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $41646.2 in 2022, then plunged by 143.49% to -$18111.1 in 2023, then soared by 69.47% to -$5530.0 in 2024, then tumbled by 156.75% to -$14198.5 in 2025, then advanced by 28.51% to -$10150.0 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$10150.0 (Q1 2026), -$14198.5 (Q4 2025), and -$5614.3 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Medicure | - | - | 2.57 Mn | -10,150.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,150.00 |
| Dec 31, 2025 | -14,198.53 |
| Jun 30, 2025 | -5,614.29 |
| Mar 31, 2025 | -9,914.29 |
| Dec 31, 2024 | -5,530.00 |
| Sep 30, 2024 | 66,800.00 |
| Jun 30, 2024 | -8,308.33 |
| Mar 31, 2024 | 1,700.00 |
| Dec 31, 2023 | -18,111.11 |
| Sep 30, 2023 | 1,540.00 |
| Jun 30, 2023 | 7,700.00 |
| Mar 31, 2023 | 10,133.33 |
| Dec 31, 2022 | 41,646.15 |
| Sep 30, 2022 | 10,445.45 |
| Jun 30, 2022 | 11,733.33 |
| Mar 31, 2022 | 9,640.00 |
| Sep 30, 2021 | -3,811.54 |
| Jun 30, 2021 | 3,562.50 |
| Mar 31, 2021 | 10,480.00 |
| Dec 31, 2020 | -14,589.06 |